Lymperopoulos, A., Rengo, G., Gao, E., Moraca, S. R., Ebert, S. N., Dorn, G. W., & Koch, W. J. (2008). Adrenal-Targeted GRK2 Gene Deletion Ameliorates Sympathetic Overstimulation and Improves Function of the Failing Heart. In Journal of Cardiac Failure (Vol. 14, pp. S34–S34). Elsevier BV. https://doi.org/10.1016/j.cardfail.2008.06.116

Lymperopoulos, Anastasios, Giuseppe Rengo, Erhe Gao, Susan R. Moraca, Steven N. Ebert, Gerald W. Dorn, and Walter J. Koch. “Adrenal-Targeted GRK2 Gene Deletion Ameliorates Sympathetic Overstimulation and Improves Function of the Failing Heart.” In Journal of Cardiac Failure, 14:S34–S34. Elsevier BV, 2008. https://doi.org/10.1016/j.cardfail.2008.06.116.

Lymperopoulos A, Rengo G, Gao E, Moraca SR, Ebert SN, Dorn GW, et al. Adrenal-Targeted GRK2 Gene Deletion Ameliorates Sympathetic Overstimulation and Improves Function of the Failing Heart. In: Journal of Cardiac Failure. Elsevier BV; 2008. p. S34–S34.

Lymperopoulos, Anastasios, et al. “Adrenal-Targeted GRK2 Gene Deletion Ameliorates Sympathetic Overstimulation and Improves Function of the Failing Heart.” Journal of Cardiac Failure, vol. 14, no. 6, Elsevier BV, 2008, pp. S34–S34. Crossref, doi:10.1016/j.cardfail.2008.06.116.

Lymperopoulos A, Rengo G, Gao E, Moraca SR, Ebert SN, Dorn GW, Koch WJ. Adrenal-Targeted GRK2 Gene Deletion Ameliorates Sympathetic Overstimulation and Improves Function of the Failing Heart. Journal of Cardiac Failure. Elsevier BV; 2008. p. S34–S34.